BCITX
Price
$11.26
Change
-$0.00 (-0.00%)
Updated
Jun 17 closing price
Net Assets
2.25B
FCCRX
Price
$11.02
Change
-$0.00 (-0.00%)
Updated
Jun 17 closing price
Net Assets
1.41B
Interact to see
Advertisement

BCITX vs FCCRX

BCITX vs FCCRX Comparison Chart in %
View a ticker or compare two or three
VS
BCITX vs. FCCRX commentary
Jun 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCITX is a Hold and FCCRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BCITX has more cash in the bank: 2.25B vs. FCCRX (1.41B). FCCRX pays higher dividends than BCITX: FCCRX (3.55) vs BCITX (3.04). BCITX was incepted earlier than FCCRX: BCITX (43 years) vs FCCRX (9 years). FCCRX (0.51) is less costly to investors than BCITX (0.47). BCITX is a more actively managed with annual turnover of: 61.00 vs. FCCRX (22.85). BCITX has a lower initial minimum investment than FCCRX: BCITX (2500) vs FCCRX (1000000). FCCRX (5.85) and BCITX (5.83) have marching annual gain over last year. BCITX return over 5 years is better than : 4.76 vs. FCCRX (2.47).
BCITXFCCRXBCITX / FCCRX
Total Expense Ratio0.470.46102%
Annual Report Gross Expense Ratio0.470.5192%
Fund Existence43 years9 years-
Gain YTD1.0961.30184%
Front LoadN/AN/A-
Min. Initial Investment250010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.25B1.41B159%
Annual Yield % from dividends3.043.5586%
Returns for 1 year5.835.85100%
Returns for 3 years10.6511.0796%
Returns for 5 years4.762.47193%
Returns for 10 years18.52N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRVS12.010.27
+2.30%
Corvus Pharmaceuticals
CTVA77.370.50
+0.65%
Corteva
KTTA0.50-0.01
-1.51%
Pasithea Therapeutics Corp
FFIN32.57-0.82
-2.46%
First Financial Bankshares
JFIN3.92-0.15
-3.69%
Jiayin Group